tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Bristol-Myers Squibb (DE:BRM)
XETRA:BRM
Germany Market
BRM
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (BRM) Stock News & Sentiment

Compare
19 Followers
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
Premium
Company Announcements
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
5d ago
BMY
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
Premium
Company Announcements
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
9d ago
BMY
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
Premium
Ratings
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
13d ago
BMY
Bristol-Myers Squibb Tracks Real-World Impact of KarXT in Schizophrenia
Premium
Company Announcements
Bristol-Myers Squibb Tracks Real-World Impact of KarXT in Schizophrenia
16d ago
BMY
Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
Premium
Market News
Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
21d ago
BMY
LLY
Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors
Premium
Company Announcements
Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors
25d ago
BMY
Bristol-Myers Squibb’s New Rheumatoid Arthritis Trial: What Early Pipeline Moves Mean for BMY Investors
Premium
Company Announcements
Bristol-Myers Squibb’s New Rheumatoid Arthritis Trial: What Early Pipeline Moves Mean for BMY Investors
27d ago
BMY
More DE:BRM News >

BRM News on the Web

1 High-Yield Dividend Stock That's Too Cheap to Ignore
The Motley Fool
Bullish
Bristol Myers announces expanded approvals for Opdivo in U.S., EU,
TipRanks News
Bullish
Bristol Myers Squibb (BMY) Gains FDA Approval for Expanded Use of Opdivo
GuruFocus News
Bullish
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
Zacks
Bullish
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)
TipRanks News
Neutral
Trump Trade: President issues short-term waiver of Jones Act
TipRanks News
Neutral
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
DE:BRM
Sector Average
Media Buzz
This Week19 articles
Weekly Average23.5 articles
News Sentiment
This Week90%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:BRM’s Media Buzz Sentiment?
19 articles about DE:BRM were published this week. In an average week, 23.5 articles are published.
    What is DE:BRM’s weekly average amount of articles?
    In an average week, 23.5 articles about DE:BRM are published.
      What is DE:BRM’s News Sentiment?
      90% of articles about DE:BRM were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        ABOSAcumen Pharmaceuticals
        KMTSKestra Medical Technologies Ltd.
        MISTMilestone Pharmaceuticals
        OVIDOvid Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week